Advertisement

BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results

11:13 EDT 9 Aug 2012 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
LYNBROOK, N.Y., Aug. 9, 2012 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia,...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results"

Search BioPortfolio:
Advertisement
Advertisement